Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval ...

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

The company emphasised that it is ready to meet the growing demand for drug-device combinations and biologics, with ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

High demand and supply shortages of weight loss drugs have presented opportunities for counterfeit drugs to enter the market.

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

Compounding pharmacies and telehealth companies saw an enormous ... The party is over — or at least it's supposed to be. "We ...

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.